Legend Biotech (LEGN) Change in Account Payables (2020 - 2026)
Legend Biotech's (LEGN) quarterly Change in Account Payables came in at -$8.1 million in Q1 2026, down 141.54% YoY from $19.5 million in Q1 2025, and down 133.38% on a QoQ basis from $24.3 million in Q3 2025.
Legend Biotech (LEGN) Change in Account Payables (2020 - 2026) Analysis & Trends
Legend Biotech (LEGN) has 7 years of Change in Account Payables data on file, last reported at -$8.1 million in Q1 2026.
- Quarterly Change in Account Payables fell 141.54% year-over-year to -$8.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $52.2 million (up 384.97% YoY) and the FY2024 annual result came in at $14.1 million, up 128.01% from the prior year.
- Change in Account Payables eased to -$8.1 million in Q1 2026, from $24.3 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $41.9 million in Q4 2022 to a low of -$34.5 million in Q4 2023.
- A 5-year average of $5.5 million and a median of $2.6 million in 2022 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables jumped 4178.72% — and 2023, when it sank 430.02%.
- Tracing LEGN's Change in Account Payables over 5 years: stood at $41.9 million in 2022, then tumbled by 182.21% to -$34.5 million in 2023, then jumped by 117.51% to $6.0 million in 2024, then surged by 302.04% to $24.3 million in 2025, then plunged by 133.38% to -$8.1 million in 2026.
- The last three Change in Account Payables figures came in at -$8.1 million (Q1 2026), $24.3 million (Q3 2025), and $16.5 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | 2.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.90 Mn |
| Jun 30, 2026 | 2.90 Mn |
| Mar 31, 2026 | -8.10 Mn |
| Mar 31, 2026 | -8.10 Mn |
| Sep 30, 2025 | 24.27 Mn |
| Sep 30, 2025 | 24.27 Mn |
| Jun 30, 2025 | 16.54 Mn |
| Jun 30, 2025 | 16.54 Mn |
| Mar 31, 2025 | 19.50 Mn |
| Mar 31, 2025 | 19.50 Mn |
| Dec 31, 2024 | 6.04 Mn |
| Dec 31, 2024 | 6.04 Mn |
| Sep 30, 2024 | -12.82 Mn |
| Sep 30, 2024 | -12.82 Mn |
| Jun 30, 2024 | -1.95 Mn |
| Jun 30, 2024 | -1.95 Mn |
| Mar 31, 2024 | 22.80 Mn |
| Mar 31, 2024 | 22.80 Mn |
| Dec 31, 2023 | -34.48 Mn |
| Dec 31, 2023 | -34.48 Mn |